We have developed a novel referencing technique for surface plasmon resonance imaging systems referred to as ''spot and hop." The technique enables internal referencing for individual flow cells in a parallel processing microfluidic network. Internal referencing provides the ability to correct for nonspecific binding and instrument drift, significantly improving data quality at each region of interest. The performance of a 48-flow-cell device was demonstrated through a series of studies, including ''rise and fall" time, ligand preconcentration, ligand immobilization, analyte binding, and regeneration tests. Interfacing parallel processing fluidics with imaging systems will significantly expand the throughput and applications of array-based optical biosensors while retaining high data quality.
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Whereas standard surface plasmon resonance (SPR) 1 biosensors have become widely adapted for molecular interaction analysis, imaging systems such as those available from Biacore (Flexchip), Genoptics, GWC, IBIS, and Maven have had less of an impact to date. Imaging systems typically involve patterning spots of ligands within a large flow cell and then testing the binding of a single analyte at a time, the so-called ''one on many" approach [1] . Two issues limit the widespread application of imaging systems. The first challenge is how to pattern protein ligands onto the sensor surface. The majority of imaging instruments rely on pin spotting, inkjet printing, and stamping methods that do not work well for many real-world applications [2] [3] [4] [5] . The necessity to immobilize outside of the flow cell often leads to lengthy optimization studies and/or irregular spots and requires high concentrations of ligands.
To address this first problem, we have developed a threedimensional microfluidic flow cell array (MFCA) [6] [7] [8] (see Fig. 1A ). This is a three-dimensional device that can deposit 48 isolated spots in a 4 Â 10-mm area [7] . A close-up image of the flow cell shape and pattern is shown in Fig. 1B . The advantage of a three-dimensional configuration over existing two-dimensional configurations is the ability to increase the density of spotting regions by having isolated spots, not flow lanes. The MFCA has dramatically outperformed pin spotting in comparison tests, making it possible to deposit ligands that are in dilute solutions as well as in crude solutions [7, 8] .
The second issue limiting the widespread adoption of imaging systems is the limited number of applications for the one on many assay approach. Most users, in fact, want to run the reverse assay; they have many analytes to test against one ligand or a few ligands. Drug discovery is a good example. In these cases, the problem is not with the imaging technology but rather with sample delivery.
In this article, we demonstrate how our MFCA devices can be used to create independent yet parallel processing flow cells when interfaced with imaging systems. We also introduce the concept of ''spot and hop" as a simple yet novel method of creating both a reaction and a reference surface within each flow cell. The current device incorporates 48 isolated flow cells that can be used to deliver different analytes to the sensor surface. Using protein A/immunoglobulin G (IgG) as a model system, we demonstrate the effectiveness of the MFCA system as well as the benefits of internal referencing. Interfacing parallel processing microfluidics with imaging technology will expand the use of array biosensor technology in drug discovery, diagnostics, and biomarker detection. 
Materials and methods
Standard MFCA printheads and an instrument were manufactured by Wasatch Microfluidics (North Salt Lake City, UT, USA). The imaging detector, a Proteomic Processor, was acquired from Plexera (Seattle, WA, USA). Protein A and bovine IgG were acquired from Sigma-Aldrich (St. Louis, MO, USA). CM5 chips were purchased from GE Healthcare (Uppsala, Sweden). The response data were processed using Scrubber 2 (Biologic Software, Campbell, Australia).
MFCA-imaging integration
Custom fixtures were adapted to the Proteomic Processor top plate to mount the MFCA above the sensor platform. Positioning x-y-z stages (Edmunds Optics, Barrington, NJ, USA) were used to provide control of the MFCA for the spot and hop movement. An MFCA instrument was adapted to provide the fluidic control for all 48 flow channels in the MFCA. A CM5 sensor chip was docked between the MFCA and Proteomic Processor's optical detector.
''Rise and fall" time test
Running buffer (phosphate-buffered saline (PBS), pH 7.4) was initially pumped through all 48 flow cells for 5 min at a flow rate of 150 ll/min to establish the baseline. A 5% solution of glycerol was then injected at the same flow rate for 10 min, followed by buffer for another 10 min.
Protein A preconcentration test
The flow system was equilibrated with PBS for 10 min prior to injecting a 10-lg/ml solution of protein A in 10 mM sodium acetate at pH 5.0. The flow rate was held constant at 150 ll/min.
The protein A solution was injected for 6 min, followed by PBS buffer.
In situ activation, immobilization, binding, and regeneration
The in situ amine coupling was accomplished using a 1:10 dilution of a mixture of N-ethyl-N 0 -(3-dimethlyaminopropyl) carbodiimide hydrochloride (EDC) and N-hydroxysuccinimide (NHS). The mixture was injected at 150 ll/min for 6 min. Protein A at 10 lg/ ml in 10 mM sodium acetate (pH 5.0) was then injected for 6 min, followed by inactivation of the ester active sites by ethanolamine (1 M, pH 8.1) for an additional 6 min. Buffer was then injected for 6 min to stabilize the baseline prior to antibody binding. Bovine IgG at 300 nM was used as an analyte. Regeneration steps were performed using HCl at dilutions of 1:1000 or 1:500.
Spot and hop test
Protein A was immobilized using amine coupling as described above onto a CM5 sensor chip. One channel was left blank without immobilization as a control. After immobilization, all liquid was removed from the MFCA. The MFCA tip was retracted and moved horizontally 0.3 mm, and then it was redocked onto the sensor surface such that each flow cell now contained a reaction and reference region of interest. Signals from the reaction and reference spot regions were set at 50 Â 50-lm squares. PBS buffer was injected to reestablish a baseline. Bovine IgG (300 nM) in 0.5% glycerol was then injected for 7 min at 150 ll/min to intentionally introduce a bulk refractive index change during the binding study. The bound IgG was removed with a subsequent regeneration step (1:500 dilution of HCl).
Results
We integrated our 48-flow-cell MFCA device with the SPR detector in a Proteomic Processor. Fig. 2 shows an SPR image of the chip surface. The dark regions represent the flow cell chambers of the 48 flow channels that appear in sharp contrast to the white background, which is where the MFCA docks with the sensor chip. The image itself is compressed slightly in the horizontal dimension due to the optics of the imaging system. Note how the shapes and positioning of the flow cell image match the physical structure of the fluidic device shown in Fig. 1 .
To test the performance of the 48-flow-cell system, we started with a basic rise and fall time experiment. As shown in Fig. 3 , we flowed buffer through the system for 5 min before switching to a sample of running buffer containing 5% glycerol in 47 of the chan- Fig. 2 . Image captured for a 48-channel MFCA directly coupled to an SPR imaging instrument. nels. At a flow rate of 150 ll/min, we observed a sharp transition in response at time 0, indicating the start of the injection. The responses from the 47 channels rapidly reached equilibrium and maintained a steady response until 600 s, at which point the sample was switched back to running buffer and the signal was decayed back to baseline. The response in the single channel without injecting the glycerol sample remained flat throughout the experiment (see bottom response in Fig. 3) .
Having demonstrated through the rise and fall time test that the fluidics was performing well across the entire flow cell array, next we wanted to demonstrate the ability to carry out chemical immobilization steps with this system. To do this, the first thing we needed to show was that the dextran-coated CM5 sensor chips, which we used as the substrate slide, would perform as anticipated for this application.
One advantage of using carboxymethyl dextran surfaces is an effect called preconcentration. This occurs when the pH of the ligand solution is low enough that the ligand takes on a positive charge and is electrostatically attracted to the negatively charged surface [9] . For this study, a sample of protein A was injected through the MFCA at a concentration of 10 lg/ml in 10 mM sodium acetate (pH 5.0). As shown in Fig. 4 , we observed an increase in response as the protein A was injected over the CM5 sensor chip. The results are nearly identical to a preconcentration study in the first reported use of dextran for SPR [9] . The sigmoidal shapes of the protein A preconcentration binding responses are consistent with concentration gradients created in the dextran layer as a result of the high capacity these surfaces have for charged proteins. The slight stagger in the responses between flow cells is due to different path lengths within the microfluidic channels. At 230 s, the flow was intentionally stopped for 10 s to observe the change in binding rate under conditions of no flow. After injecting protein A for 6 min, PBS running buffer was injected through the flow channels and the response rapidly returned to baseline as the protein A that was preconcentrated on the surface was released by the presence of higher salt (150 mM NaCl) in the buffer. This illustrates that the protein A was not irreversibly absorbed onto the sensor surface.
Having demonstrated that the fluidics and dextran surfaces were working together properly, we next ran a full in situ activation, immobilization, binding, and regeneration study. As shown in Fig. 5 , we activated the surfaces within 46 of the channels using EDC/NHS for 6 min (area a), followed by an injection of protein A (in 10 mM sodium acetate) for 6 min (area b) and then a blocking step with ethanolamine for 6 min (area c). This resulted in an average coupling response for protein A of approximately 75 response units.
Next we injected bovine IgG at a concentration of 300 nM over the protein A surfaces (see Fig. 5 , area d) and detected a significant response that averaged approximately 300 response units above background. After a 1000-s dissociation phase, the surfaces were washed with a 1:1000 dilution of HCl (area e) and a 1:500 dilution of HCl (area f) as a regeneration condition. The binding of bovine IgG was successfully repeated (area g), followed by a subsequent regeneration cycle (1-500 HCl, area h), returning the responses back to baseline. The ability to repeatedly bind IgG to the protein A surfaces demonstrates that the protein A is covalently bound to the sensor surface.
Having successfully demonstrated the ability to immobilize ligands in parallel using our microfluidic system, next we illustrate how we can create reference regions within each flow cell. After immobilizing the ligand, the MFCA printhead was withdrawn from the surface and moved horizontally approximately half a spot such that each flow cell would now occupy space over a region with and without ligand. An example of the chip image for four of the spots is shown in the inset of Fig. 6A . In these images, the lighter regions represent the areas where protein A was immobilized and the darker regions represent the reference regions.
Once redocked, the chip surfaces were washed for 10 min with PBS running buffer, followed by an injection of bovine IgG (300 nM), which contained 0.5% glycerol to intentionally add a bulk refractive index change to the responses. Fig. 6A shows the raw data collected from the reaction and reference re- gions in each flow cell. Note the significant bulk refractive index change that is recorded from the reference regions and is present in the reaction regions as well. Two flow cells were used as controls. In one flow cell, we injected buffer only, and this gave no response (see flat lines in Fig. 6A ). The second flow cell had the IgG sample but no protein A immobilized and showed only the bulk refractive index change.
Finally, we used the responses from the reference regions to subtract the bulk refractive index changes and any nonspecific binding or drift that was present in each flow cell. Fig. 6B shows the reference-corrected data for the IgG injection. The standard deviation in the binding response was less than 10% and likely stems from slightly different levels of immobilized protein A. The two responses with no significant change in signal are from the two reference flow cells.
Discussion
In this study, we interfaced our parallel array of 48 microchannel flow cells with an SPR imaging system called the Proteomic Processor. In this case, the open format of the Proteomic Processor made it easy to integrate to the prism and chip holder. We used custom fixtures and positioning stages to enable accurate retraction and horizontal movement of the flow cells for the spot and hop experiments as well as for removing and inserting sensor chips.
The rapid changes in response observed in the rise and fall time experiments demonstrated that our system has the potential to be used in kinetic binding studies. We also demonstrated the ability to carry out multistep immobilization methods using sequential injections of activation, coupling, and blocking conditions. In addition, we showed that we could reproducibly bind an analyte and regenerate bound complexes. We employed amine coupling on dextran-coated surfaces from Biacore because these surfaces are readily available, and this chemistry is commonly used. But our fluidic system should be able to handle other immobilization methods and surface chemistries.
By repositioning the flow cells after the immobilization step, our spot and hop method makes it possible to create independent reaction and reference regions of interest within each flow cell. We applied the internal referencing step to data collected for the binding of IgG to immobilized protein A. The resulting binding responses appeared to be very consistent between the different flow cells. But although the responses have a classic shape, the kinetics are in fact complicated by the fact that the interaction of protein A with IgG is not simply 1:1 [10] . However, these data do demonstrate that internal referencing can significantly improve the quality of response data by providing the means to remove bulk refractive index changes, instrument drift, and nonspecific binding.
The MFCA-imaging integrated platform illustrates the potential for a parallel high-throughput detection platform. The ability to test 48 samples at one time opens up a number of unique experimental options. For example, in a screening mode, users may test the binding properties of 48 different analytes (e.g., antibodies, small molecules). The technology could also expand biophysical studies. Because the flow paths are completely independent of one another, and because each contains its own internal reference, it is possible to test the binding of one analyte under different buffer conditions (e.g., pH, salt, detergents).
Given the potential throughput of our system, we are currently working on developing an automated sample introduction station to handle reagents in 96-and 384-well plate formats. We are also looking into the potential of scaling up the number of channels in our device from 48 to 96 independent flow cells to enhance throughput even further. Finally, by incorporating finer motion controls on the docking station, we are investigating the potential to spot multiple times within each flow cell.
Conclusion
The MFCA was successfully integrated with an existing commercial imaging platform, the Proteomic Processor, making it possible to analyze 48 analyte samples in parallel. We demonstrated good system performance and the ability to perform in situ immobilization. Our unique spot and hop approach to referencing can provide a useful tool for reducing system artifacts and improving data quality. Our technology offers the means to capitalize on currently available imaging systems by significantly expanding throughput as well as applications.
